Inventiva (IVA) EBITDA (2019 - 2025)
Inventiva (IVA) recorded quarterly EBITDA of $880664.6 in Q2 2025, up 1277.33% quarter-over-quarter from -$74801.7 in Q4 2024, and up 1268.27% on a YoY basis from $64363.5 in Q2 2024.
Inventiva (IVA) EBITDA (2019 - 2025) Analysis & Trends
Inventiva's EBITDA history runs 7 years deep, the most recent figure standing at $880664.6 for Q2 2025.
- In Q2 2025, EBITDA rose 1268.27% year-over-year to $880664.6; the TTM figure through Jun 2025 stood at $880664.6 (up 1268.27% YoY), while the FY2025 annual figure was -$164.1 million, down 219340.62% from the prior year.
- EBITDA was $880664.6 for Q2 2025 at Inventiva, up from -$74801.7 in the prior quarter.
- In the past five years, EBITDA ranged from a high of $880664.6 in Q2 2025 to a low of -$16.5 million in Q2 2021.
- Historically, EBITDA has averaged -$3.5 million across 5 years, with a median of -$178852.7 in 2022.
- The sharpest annual moves came in 2021 and 2025: EBITDA slumped 68.62% in 2021, then surged 1268.27% in 2025.
- A 5-year view of EBITDA shows it stood at -$16.5 million in 2021, then jumped by 98.57% to -$234656.9 in 2022, then decreased by 4.54% to -$245314.3 in 2023, then surged by 69.51% to -$74801.7 in 2024, then soared by 1277.33% to $880664.6 in 2025.
- The last three EBITDA figures came in at $880664.6 (Q2 2025), -$74801.7 (Q4 2024), and -$75382.1 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -14.44 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -65.83 Mn |
| 10 | Inventiva | 8.78 Mn | -259.95 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 880,664.64 |
| Dec 31, 2024 | -74,801.68 |
| Jun 30, 2024 | -75,382.13 |
| Dec 31, 2023 | -245,314.30 |
| Jun 30, 2023 | -123,048.46 |
| Dec 31, 2022 | -234,656.89 |
| Jun 30, 2021 | -16.46 Mn |
| Mar 31, 2021 | -11.99 Mn |
| Dec 31, 2020 | -35.43 Mn |
| Jun 30, 2020 | -9.76 Mn |
| Mar 31, 2020 | -7.51 Mn |
| Dec 31, 2019 | -33.55 Mn |